U.S. flag

An official website of the United States government

NM_001267550.2(TTN):c.67318G>A (p.Gly22440Ser) AND Cardiovascular phenotype

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 11, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002354351.2

Allele description [Variation Report for NM_001267550.2(TTN):c.67318G>A (p.Gly22440Ser)]

NM_001267550.2(TTN):c.67318G>A (p.Gly22440Ser)

Genes:
TTN-AS1:TTN antisense RNA 1 [Gene - HGNC]
TTN:titin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q31.2
Genomic location:
Preferred name:
NM_001267550.2(TTN):c.67318G>A (p.Gly22440Ser)
HGVS:
  • NC_000002.12:g.178579969C>T
  • NG_011618.3:g.255834G>A
  • NG_051363.1:g.62143C>T
  • NM_001256850.1:c.62395G>A
  • NM_001267550.2:c.67318G>AMANE SELECT
  • NM_003319.4:c.40123G>A
  • NM_133378.4:c.59614G>A
  • NM_133432.3:c.40498G>A
  • NM_133437.4:c.40699G>A
  • NP_001243779.1:p.Gly20799Ser
  • NP_001254479.2:p.Gly22440Ser
  • NP_003310.4:p.Gly13375Ser
  • NP_596869.4:p.Gly19872Ser
  • NP_597676.3:p.Gly13500Ser
  • NP_597681.4:p.Gly13567Ser
  • LRG_391:g.255834G>A
  • NC_000002.11:g.179444696C>T
  • NM_001267550.2:c.67318G>A
  • NM_003319.4:c.40123G>A
Protein change:
G13375S
Links:
dbSNP: rs727503576
NCBI 1000 Genomes Browser:
rs727503576
Molecular consequence:
  • NM_001256850.1:c.62395G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001267550.2:c.67318G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003319.4:c.40123G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133378.4:c.59614G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133432.3:c.40498G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133437.4:c.40699G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002621128Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Jul 11, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.

Marian AJ, Tan Y, Li L, Chang J, Syrris P, Hessabi M, Rahbar MH, Willerson JT, Cheong BY, Liu CY, Kleiman NS, Bluemke DA, Nagueh SF.

Circ Res. 2018 Apr 13;122(8):1109-1118. doi: 10.1161/CIRCRESAHA.117.312647. Epub 2018 Mar 14.

PubMed [citation]
PMID:
29540445
PMCID:
PMC5899034

Details of each submission

From Ambry Genetics, SCV002621128.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The p.G13375S variant (also known as c.40123G>A), located in coding exon 145 of the TTN gene, results from a G to A substitution at nucleotide position 40123. The glycine at codon 13375 is replaced by serine, an amino acid with similar properties. This variant (reported as p.G22440S, c.67318G>A) has been detected in a hypertrophic cardiomyopathy cohort; however, details were limited (Marian AJ et al. Circ. Res., 2018 Apr;122:1109-1118). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 16, 2025